ESR1 and breast carcinoma: The ER+ breast cancer cell lines used in this study (MCF7, SUM44, HCC1428, T47D, and ZR-75–1; Supplementary Table S1) were chosen to encompass a range of ER+ breast cancer molecular phenotypes.